Trained in molecular and computational biology and jointly appointed in Medicine and Genetics, Dr. Christina Curtis pursues systems biology and computational approaches to establish a quantitative and mechanistic understanding of cancer progression. Dr. Curtis’s laboratory leverages multi-omic data coupled with computational modeling and iterative experimentation in order to define the molecular determinants and dynamics of tumor progression and to identify robust biomarkers. Her research has helped to redefine the molecular map of breast cancer and led to new paradigms in understanding how human tumors progress. Dr. Curtis is the recipient of the awards from the V Foundation for Cancer Research, STOP Cancer, the AACR, and is a Kavli Fellow of the National Academy of Sciences. She received the National Institutes of Health Director's Pioneer Award in 2018 and was named a Komen Scholar in 2020. Dr. Curtis is the principal investigator on grants from the NIH/NCI, NHGRI, Department of Defense, American Association for Cancer Research, Breast Cancer Research Foundation, Susan G. Komen Foundation, and Emerson Collective. She serves on the Editorial Boards of Breast Cancer Research, Cancer Discovery, Carcinogenesis: Integrative Biology, Cell Systems, JCO Precision Oncology, and the Journal of Computational Biology.
Listen to the interview with Christina (published November 2021) https://mendelspod.com/podcasts/tumor-evolution-context-christina-curtis/